+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Donor Egg IVF Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029

  • PDF Icon

    Report

  • 114 Pages
  • October 2021
  • Region: Global
  • Acute Market Reports
  • ID: 5614574

Industry Outlook


The donor egg IVF treatment market is set to reach US$ 4,294.5 Mn by 2029 from US$ 2,081.4 Mn in 2020 highlighting moderate growth at a compounded annual growth rate (CAGR) of 8.4% during the forecast period from 2021 to 2029. In the last 2 decades there has been a paradigm shift observed in the society which has major influence over the consistently growing infertility rate. Significant rise in working women, delayed marriages, advanced maternal age etc provide a positive impetus for the donor egg IVF treatment market.

High success rate associated with pregnancy and efficiency in retrieving viable embryos derive the fresh donor egg IVF cycle market


Fresh donor egg IVF cycle is reigning the cycle type segment for donor egg IVF treatment market. The advantages associated with fresh donor egg IVF treatment cycle are high success rate associated with pregnancy and efficient method to retrieve viable embryos. The limitation associated with this cycle type is long waiting period. Frozen donor egg IVF cycle market are gaining traction on account of effective screening, consistent cohorts ready to be shipped, thawed and used as per clients schedule. Change in lifestyle and family planning motivate people to freeze eggs for future children and siblings.

Technological advancement in IVF treatment protocols and state of the art capital equipments drive the fertility clinics market growth


Fertility clinics are dominating the end user segment for donor egg IVF treatment market. Inherent features such as technological advancement in IVF treatment protocols such as egg freezing, hatching, vitrification, gamete intrafallopian transfer (GIFT) etc. provide the necessary impetus for the market growth of fertility clinics worldwide. Healthcare agencies in developed countries are providing huge financial aid to establish IVF treatment centers in hospitals to cater services to people in remote areas

Rising prevalence of menopause and increasing public health awareness related to infertility drive the market growth in North America region


North America with a market share of 34% is the leading regional segment for donor egg IVF treatment market. The paramount factors responsible for its dominance are rising prevalence of menopause. As per the statistics provided by American Congress of Obstetricians and Gynecologists approximately 2 million women reach early menopause annually. Increasing public health awareness related to infertility will propel the market growth in the region. Europe accounts for 32% market share owing to change in lifestyle prioritizing professional career over personal life, and hence opting for late stage pregnancy induced via IVF treatment. Asia Pacific is representing 24% market growth on account of significant rise in fertility clinics and increasing fertility tourism as IVF treatment is available at affordable price.

Historical & Forecast Period


This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2021 to 2029.Pharmaceutical companies specializing in providing IVF treatment services are Cook Medical, Inc., EMD Serono, Inc., Flinders Reproductive Medicine Pty. Ltd., Fertility First, Genea Oxford Fertility Limited, OvaScience, Procrea Fertility, Progyny, Inc., ReproMed and Vitrolife AB.

Key questions answered in this report

  • Which major players are competing in the donor egg IVF treatment market?
  • What are the organic and inorganic market growth strategies to determine the latest market trend?
  • What are the different factors responsible for infertility in women?
  • Which factors are related to the growing popularity of fresh donor egg IVF cycle?
  • Which sophisticated IVF treatment protocols are available in the fertility clinics?
  • What will be the market size and CAGR for Asia Pacific region during the forecast period?


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Donor Egg IVF Treatment Market Portraiture
2.2. Global Donor Egg IVF Treatment Market, by Cycle Type, 2020 (US$ Mn)
2.3. Global Donor Egg IVF Treatment Market, by End User, 2020 (US$ Mn)
2.4. Global Donor Egg IVF Treatment Market, by Geography, 2020 (US$ Mn)
Chapter 3. Donor Egg IVF Treatment Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2020
3.6. Competitive Analysis: Global Donor Egg IVF Treatment Market, by Key Players, 2020
Chapter 4. Global Donor Egg IVF Treatment Market, by Cycle Type
4.1. Overview
4.2. Fresh Donor Egg IVF Cycle
4.3. Frozen Donor Egg IVF Cycle
Chapter 5. Global Donor Egg IVF Treatment Market, by End User
5.1. Overview
5.2. Fertility Clinic
5.3. Hospital
5.4. Clinical Research Institute
Chapter 6. Global Donor Egg IVF Treatment Market, by Geography
6.1. Overview
6.2. North America Donor Egg IVF Treatment Market Analysis, 2019 - 2029
6.2.1. North America Donor Egg IVF Treatment Market, by Cycle Type, 2019 - 2029 (US$ Mn)
6.2.2. North America Donor Egg IVF Treatment Market, by End User, 2019 - 2029 (US$ Mn)
6.2.3. North America Donor Egg IVF Treatment Market, by Country, 2019 - 2029 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Donor Egg IVF Treatment Market Analysis, 2019 - 2029
6.3.1. Europe Donor Egg IVF Treatment Market, by Cycle Type, 2019 - 2029 (US$ Mn)
6.3.2. Europe Donor Egg IVF Treatment Market, by End User, 2019 - 2029 (US$ Mn)
6.3.3. Europe Donor Egg IVF Treatment Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Donor Egg IVF Treatment Market Analysis, 2019 - 2029
6.4.1. Asia Pacific Donor Egg IVF Treatment Market, by Cycle Type, 2019 - 2029 (US$ Mn)
6.4.2. Asia Pacific Donor Egg IVF Treatment Market, by End User, 2019 - 2029 (US$ Mn)
6.4.3. Asia Pacific Donor Egg IVF Treatment Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Donor Egg IVF Treatment Market Analysis, 2019- 2029
6.5.1. Latin America Donor Egg IVF Treatment Market, by Cycle Type, 2019 - 2029 (US$ Mn)
6.5.2. Latin America Donor Egg IVF Treatment Market, by End User, 2019 - 2029 (US$ Mn)
6.5.3. Latin America Donor Egg IVF Treatment Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Donor Egg IVF Treatment Market Analysis, 2019 - 2029
6.6.1. MEA Donor Egg IVF Treatment Market, by Cycle Type, 2019 - 2029 (US$ Mn)
6.6.2. MEA Donor Egg IVF Treatment Market, by End User, 2019 - 2029 (US$ Mn)
6.6.3. MEA Donor Egg IVF Treatment Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Cook Medical, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. EMD Serono, Inc.
7.3. Flinders Reproductive Medicine Pty Ltd.
7.4. Fertility First
7.5. Genea Oxford Fertility Limited
7.6. OvaScience
7.7. Procrea Fertility
7.8. Progyny, Inc.
7.9. ReproMed

Companies Mentioned

  • Cook Medical Inc.
  • EMD Serono Inc.
  • Flinders Reproductive Medicine Pty. Ltd.
  • Fertility First
  • Genea Oxford Fertility Limited
  • OvaScience
  • Procrea Fertility
  • Progyny Inc.
  • ReproMe. Vitrolife AB.